GlassScriptPhysician profile
Vishal C Patel
NPI 1255542262
$2,504.44
in general payments reported to CMS, 2019-2025
19 companies · $146 in 2025
The $146 reported for 2025 was less than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $691 · 2020: $687 · 2021: $147 · 2022: $613 · 2023: $91.70 · 2024: $128 · 2025: $146.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $366.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $365.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $556.33 | 2019-2024 | Tacticath Ablation Catheter, Sensor Enabled |
| Astrazeneca Pharmaceuticals LP | $517.28 | 2019-2025 | Saphnelo |
| Medtronic, INC. | $406.65 | 2021-2025 | Percept PC Brainsense |
| Gilead Sciences, INC. | $131.91 | 2020-2024 | |
| Cvrx, INC. | $125.91 | 2022 | |
| Nevro Corp. | $122.55 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $122.25 | 2019-2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $95.67 | 2020 | |
| Medtronic Vascular, INC. | $86.04 | 2019 | |
| Pfizer INC. | $68.84 | 2022-2024 | |
| Janssen Pharmaceuticals, INC | $61.28 | 2019-2020 | |
| Novartis Pharmaceuticals Corporation | $53.48 | 2021-2023 | |
| Novo Nordisk INC | $49.87 | 2020-2021 | |
| Janssen Biotech, INC. | $33.82 | 2022 | |
| Teva Pharmaceuticals USA, INC. | $17.63 | 2020 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Eisai INC. | $14.76 | 2021 | |
| Glaxosmithkline, LLC. | $13.89 | 2020 | |
| Lilly USA, LLC | $13.60 | 2020 | |
| Boston Scientific Corporation | $12.68 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Vishal Patel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.